Over the latest trailing 12-month period, total return cagr is +9.50%. The comparable SPY value is +16.94%. Year-to-date total return is -51.07%. Total return includes price appreciation and reinvested dividends.
Over longer horizons, Total Return CAGR averages 5.22% over 3 years and -44.39% over 5 years; the trailing 12 months came in at +9.50%. Total return includes dividends reinvested. The total return CAGR includes both price appreciation and dividends reinvested. This gives a more complete picture of the company's investment performance.
Insight Molecular Diagnostics Inc. (IMDX)
Total Return growth vs the same calendar quarter one year earlier, last 36 comparable quarters.
Quarter-end value of $100 invested at the start of the available history, with dividends reinvested; the newest quarter may be quarter-to-date. Q4 2026 (2026-10-05): $2.27.
| Year | Total return for the year |
|---|---|
| 2026 (YTD) | -51.07% |
| 2025 | +215.13% |
| 2024 | -4.80% |
| 2023 | -61.06% |
| 2022 | -85.21% |
| 2021 | -9.21% |
| 2020 | +6.22% |
| 2019 | +63.04% |
| 2018 | -70.32% |
| 2017 | -34.04% |
| 2016 | +12.80% |
| Period | Period End | QoQ Return | YoY Return |
|---|---|---|---|
| Q4 2026 (QTD) | 2026-10-05 | +15.4% | -47.6% |
| Q3 2026 | 2026-09-28 | -41.3% | -4.2% |
| Q2 2026 | 2026-06-29 | +52.2% | +60.8% |
| Q1 2026 | 2026-03-27 | -49.1% | +16.3% |
| Q4 2025 | 2025-12-30 | +110.8% | N/A |
| Q3 2025 | 2025-09-30 | -1.5% | N/A |
| Q2 2025 | 2025-06-26 | +10.1% | N/A |
| Q1 2025 | 2025-03-31 | N/A | N/A |
| Q4 2024 | 2024-12-31 | N/A | N/A |
| Q3 2024 | 2024-09-26 | N/A | -4.8% |
| Q2 2024 | 2024-06-27 | N/A | -36.5% |
| Q1 2024 | 2024-03-27 | N/A | -46.8% |
| Q4 2023 | 2023-12-29 | -19.9% | -58.3% |
| Q3 2023 | 2023-09-29 | -32.2% | -79.2% |
| Q2 2023 | 2023-06-30 | -17.9% | -73.3% |
| Q1 2023 | 2023-03-30 | -6.7% | -81.5% |
Calendar returns: QoQ compares the prior calendar quarter; YoY compares the same calendar quarter a year earlier. The newest quarter is in progress (quarter-to-date).
